When should a blood thiamine assay be ordered, what are the interpretive reference ranges, and how should confirmed or borderline thiamine deficiency be managed?

Blood Thiamine Assay

Measure RBC or whole blood thiamine diphosphate (ThDP) in patients with cardiomyopathy on prolonged diuretics, those undergoing nutritional assessment for prolonged medical nutrition or post-bariatric surgery, patients at risk for refeeding syndrome, and any patient with encephalopathy. 1

When to Order Blood Thiamine Testing

The 2022 ESPEN guidelines provide clear indications for thiamine measurement 1:

• Cardiomyopathy with prolonged diuretic treatment - diuretics increase renal thiamine losses
• Nutritional assessment contexts: prolonged medical nutrition support and post-bariatric surgery patients (thiamine is among the highest-risk micronutrients for deficiency in this population)
• Refeeding syndrome - to prevent catastrophic exacerbation when nutrition is reintroduced
• Any encephalopathy - including unexplained altered mental status, not just alcohol-related cases

Important Clinical Context

Do not limit thiamine assessment to patients with alcohol use disorder. Recent evidence demonstrates thiamine deficiency occurs in 20% of emergency department patients with sepsis, diabetic ketoacidosis, and oncologic emergencies even without alcohol history 2. Critical illness is associated with thiamine depletion in >90% of patients 1. Deficiency is also common in pregnancy (heightened metabolic demands), chronic malnutrition, malignancies, continuous renal replacement therapy, and prolonged parenteral nutrition 1, 3.

Thiamine reserves deplete within 20 days of inadequate intake 1, making early recognition critical to prevent irreversible neurologic damage.

What to Measure

The preferred test is RBC or whole blood thiamine diphosphate (ThDP) - Grade A recommendation 1. This is the bioactive form that best reflects body stores and is not affected by inflammation 1.

• Reference range for whole blood ThDP: 84.3 to 213.3 nmol/L 4
• Alternative if ThDP unavailable: Red cell transketolase activity with thiamine activation coefficient 1

Avoid plasma free thiamine - it reflects recent dietary intake rather than body stores and is less reliable for assessing true deficiency status 4.

Critical Pitfall

Do not wait for laboratory confirmation before treating. Symptoms and signs lack sensitivity and specificity in critically ill patients, and deficiency is frequently underdiagnosed 5. MRI and serum thiamine levels often lack sensitivity early in disease 6.

Interpretation and Management

Confirmed Deficiency (Low Blood ThDP)

For mild deficiency without acute illness (low dietary intake, low ThDP, no clinical symptoms):

• 10 mg/day orally for 1 week, then 3-5 mg/daily for at least 6 weeks 1

For high suspicion or proven deficiency with acute presentation:

• 200 mg three times daily IV 1

For encephalopathy of uncertain etiology (including Wernicke's):

• 500 mg three times daily IV 1
• This aggressive dosing is critical as acute mortality of Wernicke-Korsakoff syndrome is approximately 20% 7

Borderline or At-Risk Patients

For patients at risk without confirmed deficiency:

• 100 mg three times daily IV 1

For hospitalized patients with suspected reduced food intake or high alcohol consumption:

• 100-300 mg/day by oral or IV route 1

For emergency/ICU admissions:

• 100-300 mg/day IV for 3-4 days without hesitation from admission - Grade B recommendation 1

Route Selection Algorithm

Use IV route when:

• Any acute disease present
• Suspicion of inadequate intake, even short-term
• Encephalopathy or neurologic symptoms
• Alcohol-related gastritis (impairs oral absorption) 1

Oral route acceptable when:

• Chronic deficiency suspected without acute disease
• Maintenance therapy after IV loading (50-100 mg/day) 1

Special Populations

• Refeeding syndrome: 300 mg IV before initiating nutrition, then 200-300 mg IV daily for ≥3 days 1
• Chronic diuretic therapy: 50 mg/day orally 1
• Continuous renal replacement therapy: 100 mg/day 1
• Pregnancy with deficiency: IV thiamine with close monitoring; deficiency can present as gastric beriberi, paraparesis, high-output heart failure, or acute pulmonary hypertension 3

Safety Considerations

Thiamine has no upper limit for toxicity 1. Anaphylaxis risk with IV administration is <1 in 100,000 7. Doses >400 mg may cause mild nausea, anorexia, or ataxia 1. The safety profile strongly favors empiric treatment in high-risk scenarios rather than delaying for laboratory confirmation.